In this issue:
Offer screening colonoscopy to HIV-infected?
Stepped-dose efavirenz reduces neuropsychiatric events
GPT improves survival in HIV
Understanding (non)-adherence in HAART
Boosted darunavir: less virological failure
Abacavir/lamivudine viable first-line HIV therapy
Tenofovir: liver and bone toxicity
Expanding in vitro microbicide safety testing
Real-time PCR detecting HIV at the point of care
Circumcision reduces HIV risk in men only
Please login below to download this issue (PDF)